[122] Richardson GM, Wilson R, Allard D, Purtill C, Douma S, Gravire J
Other factors which may increase the risk of hypoglycemia include changes in meal pattern (e.g., macronutrient content or timing of meals), changes in level of physical activity, or changes to concomitant drugs [see DRUG INTERACTIONS ]
Links open on PubMed, PubMed Central, or the publisher in a new tab
One month after the sixth injection, the feedback score obtained from the patients showed a median score of 4.99 and most patients (n=90, 31.8%) reported 5 on the scale of 1 to 7 (Table 5)
The world of wellness is often clouded by products that look good on paper but fail to provide the body with what it needs in a form it can actually use
Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater in the presence of weight-related comorbidities such as prediabetes/type 2 diabetes, hypertension, dyslipidaemia or obstructive sleep apnoea
